19 results on '"Mirtti T"'
Search Results
2. 793 - The spatial distribution of positive cores predicts outcomes of active surveillance in very low risk prostate cancer patients
3. 795 - PTEN status in diagnostic biopsies predicts active surveillance rebiopsy Gleason upgrade, treatment change and adverse surgical histopathological findings
4. 80P Oncolytic adenovirus type 3 coding for CD40L facilitates dendritic cell therapy of prostate cancer in humanized mice and patient samples
5. 1135 - A population-based randomized trial of early detection of clinically significant prostate cancer (ProScreen): Pilot phase results
6. 995 - Stat5 mediates enzalutamide-resistant prostate cancer growth
7. 101 - Positive status for STAT5 locus amplification in conjunction with STAT5 protein expression is a powerful predictor of recurrence after radical prostatectomy
8. 66 - Prostate cancer active surveillance: Longitudinal health-related quality of life, IPSS and IIEF changes in the Finnish arm of the prospective PRIAS study with up to nine-years of follow-up
9. 3 - Precision systems medicine in urological Tumors – Molecular profiling and functional testing
10. 525 - Utilization of next-generation sequencing techniques to investigate markers for chemosensitivity in bladder cancer patients treated with neoadjuvant chemotherapy prior to radical cystectomy
11. 851 - Association of angiopoietin-2 and Ki-67 expression with vascular density and sunitinib response in metastatic renal cell carcinoma
12. 37 - Outcome of surgery for patients with renal cell carcinoma and tumour thrombus in the era of modern targeted therapy
13. 4 - Performance of serial multiparametric MRI among the Finnish arm of the PRIAS active surveillance cohort of patients with Gleason 3+3 prostate cancer
14. Le Fibroblast Growth Factor Receptor 3 (FGFR3), cible thérapeutique pour le traitement personnalisé du cancer de la vessie : validation anatomo-pathologique du concept
15. P155 Loss of PTEN expression together with ERG overexpression leads to shorter disease-specific survival in prostate cancer after radical prostatectomy
16. 412 Pathological validation of adjuvant anti-fibroblast growth factor receptor 3 (FGFR3) treatment for bladder cancer
17. 154 MAC387 positive tumor-associated macrophage count is an independent predictor of poor survival after radical cystectomy for urothelial bladder cancer
18. 905 Hypoxia is independently associated with poor outcome in urothelial bladder cancer patients treated with radical cystectomy
19. The ERGoncogene modulates WNT signaling and cell adhesion in human prostate cancer cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.